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ABSTRACT 
Background 
There are two principal types of oesophageal carcinoma with squamous cell 
carcinoma being the most common globally.  There are several different etiological 
factors in the development of oesophageal squamous cell cancer (OSCC).  The 
significance of these risk factors appears to vary by region.  The human 
papillomavirus has been implicated in the aetiology of OSCC.  Furthermore, it has 
been postulated that the differences in the prevalence of HPV in OSCC is related 
to the geographical region in which the study was conducted with HPV playing a 
more significant role in high risk areas.   
Aim 
The aim of this study was to establish the presence or absence of HPV infection in 
the oesophagus and any association it may have with oesophageal squamous cell 
carcinoma. 
Materials and methods 
All cases of oesophageal squamous cell carcinoma that were diagnosed between 
01 January 2009 and 31 December 2010 at Chris Hani Baragwanath Hospital were 
included in the study.  All the cases were assessed for the presence or absence of 
condylomatous atypia.  PCR was performed on all the cases as well as on 10 
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cases of normal control oesophageal biopsies. PCR was performed using the 
GP5+ and GP6+ primers.   
Results  
The database search revealed 96 eligible cases of which 95 showed amplification 
of the β-globin gene and underwent PCR.  Of these, two cases showed histological 
features of condylomatous atypia.  All 95 cases failed to demonstrate the presence 
of HPV DNA by PCR. 
Conclusion 
HPV is a common infection in the South African population and is known to be 
carcinogenic in other sites.  Its role in OSCC has remained controversial, however, 
this study does not support the theory that HPV has a role to play in the 
pathogenesis of OSCC. 
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CHAPTER 1 
1.0 INTRODUCTION 
There are two principal types of oesophageal carcinoma, namely adenocarcinoma 
of the oesophagus and squamous cell carcinoma of the oesophagus, with 
squamous cell carcinoma being more common than adenocarcinoma globally.  
Several other epithelial and non-epithelial tumours have also been described, such 
as carcinoid tumours, sarcomas and melanomas (1).   
Adenocarcinoma of the oesophagus most commonly arises in the background of 
Barrett oesophagus which develops in the setting of chronic gastro-oesophageal 
reflux disease (2). 
There are several different etiological factors in the development of oesophageal 
squamous cell cancer (OSCC).  The significance of these different risk factors 
appears to vary by geographical location (3).  
Alcohol and tobacco are considered the primary aetiology of most cases of OSCC 
that are diagnosed in Western countries, accounting for more than 90% of the 
cases.  Although both are significant in the aetiology of OSCC individually, together 
the effects of their toxins are multiplied, increasing the chances of developing 
OSCC (4).  Another substance of abuse that is implicated as a cause is opium (4, 5), 
which when smoked, exposes the individual to carcinogens that may be involved in 
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the aetiology of OSCC (6).  
Nutritional factors as a cause for OSCC include temperature factors, nutritional 
deficiencies and contamination.  In parts of South America where a herbal 
beverage is consumed very hot, the almost burning temperature of the drink is 
considered to be a risk factor for the development of OSCC possibly due to the 
chronic oesophagitis caused by the excessively high temperatures. This has been 
mirrored in studies from other countries assessing the intake of other hot drinks (4).  
In some regions, deficiencies of vitamins and trace elements are considered critical 
to the development of OSCC (5).     
Contamination of food by fungi is known to potentially produce nitrosamines or the 
precursors of nitrosamines.  These are thought to be important in the development 
of OSCC (5).  In South Africa it is the consumption of Fusarium fungal contaminated 
home-brewed beer that has been postulated as the aetiological agent owing to its 
nitrate reducing capabilities and its subsequent production of carcinogenic 
nitrosamines (7).  
Human papillomavirus (HPV) has been implicated in the aetiology of OSCC but 
this has not been proven definitively (4).  This association, however, seems to be 
most significant in high risk areas only (1).  
In view of South Africa‟s high risk rate for oesophageal carcinoma, I decided to 
investigate the presence of HPV DNA in OSCC in a large series of patients 
attending Chris Hani Baragwanath Hospital.
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CHAPTER 2 
2.0 AIMS AND OBJECTIVES 
The aim of this study was to determine the presence or absence of HPV DNA in 
oesophageal squamous cell carcinoma.  If HPV DNA is detected in a statistically 
significant number of OSCC cases and not in normal oesophageal biopsies a 
causal relationship can be supported. 
The objectives were to: 
1. Determine the presence of HPV-DNA using PCR in a large series of cases 
diagnosed over a two year period. 
2. Determine the age, gender and race of the patients diagnosed with this form 
of carcinoma. 
3. Assess for the presence or absence of condylomatous atypia in cases of 
OSCC and compare this to the PCR findings. 
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CHAPTER 3 
3.0 LITERATURE REVIEW 
3.1 Epidemiology and demographics of squamous cell 
carcinoma of the oesophagus 
In 2002, cancer of the oesophagus was the sixth most diagnosed cancer in men 
and the ninth most diagnosed cancer in women globally as reported by the 
International Agency for Research on Cancer.  It has a dismal 5-year survival rate 
of less than 10% worldwide (3).  It has a high variation in incidence worldwide, with 
more than a fifty- fold variation in incidence between high and low risk areas (8). 
The countries with the highest documented risk for oesophageal cancer are parts 
of Iran, China, Kazakhstan (4) as well as East and South Africa (8).The areas with 
the lowest recorded levels of oesophageal cancer are Western Africa and South 
Eastern parts of Asia (8). 
Oesophageal squamous cell carcinoma is diagnosed more frequently in men than 
women with a 2-10 times higher incidence (4). It is most common in adults over the 
age of 45 years (1). 
Racial and ethnic differences have been noted in the incidence of OSCC.  It is 
more prevalent amongst African-Americans as compared to Caucasian Americans 
(4) with a nearly six times higher incidence in African Americans (1).  In central Asia, 
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Caucasians are at a lower risk as compared to individuals of Turkish or Mongolian 
descent (4). 
 3.2 HPV oncological potential 
HPV has been investigated with relation to cervical cancer for many years (9).  
Through this well established association, it has earned the reputation of having 
oncogenic potential (5).   It has further been linked to cancer of the vulva, vagina, 
penis, anus and oropharynx (9).   Its role in the causation of OSCC remains 
inconclusive in the literature (10). 
3.3 HPV subtypes 
To date, over 140 types of HPV have been described (11).  The L1 gene is the most 
conserved gene in the HPV genome and therefore, this gene is used when 
classifying new HPV types.  In 1995, at the International Papillomavirus Workshop, 
a new definition was decided upon using the L1 gene as a reference.  A new HPV 
type is only classified as such when, following genome cloning and subsequent 
analysis of the L1 gene, it is shown that this new type differs by more than 10% 
from the closest known HPV type.  If this difference is in the range of 2-10%, it is 
classified as a subtype and if less than 2%, it is classified as a variant (12).  
The oncogenic potential of the HPV types are classified according to their 
prevalence in cervical cancer.   These classifications are high-risk, low-risk or a 
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probably high-risk type (9). 
The HPV types with an undisputable link to cervical cancer have been classified as 
high-risk types.  These high-risk types include HPV types 16, 18, 31, 33, 35, 39, 
45, 51, 52, 56, 58 and 59 (9).  Worldwide, HPV types 16, 18, 31 and 45 have been 
attributed with causing over 90% of all cervical squamous cell carcinomas (13).  Of 
these four, HPV 16 deserves a special mention as it single-handedly can be linked 
to over 50% of these cancers (14).   
Low-risk types are HPV types 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81 and CP6108 
(9).  These types are attributed with causing benign warts and are not considered to 
be oncogenic (13). 
The third category that exists is termed „probably high-risk‟.  The types that fall into 
the probably high-risk category are 26, 53, 66, 68, 73 and 82.  They are classified 
as such as they have been detected in cases of cervical cancer but there is 
insufficient literature to assess their oncogenic potential (9).   
3.4 HPV genome 
HPV is a circular, double-stranded DNA virus that invades the mucous membranes 
and basal cutaneous cells where it makes use of the host cells‟ DNA replication 
mechanisms to reproduce itself (9).   It usually exists as a nuclear episome but it is 
also capable of integrating its genome into the host‟s genome.  This integration has 
been found to lead to an unstable genome, allowing for malignant transformation to 
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occur (15). 
The HPV genome consists of 8 genes.  There are 6 non-structural genes (E1, E2 
and E4-7) and 2 genes coding for capsid proteins (L1 and L2) (15).  
Each gene has a different function.  The L1 and L2 genes code for a major and a 
minor capsid protein respectively.  L2 also aids in the assembly of intact virions.  
The E1 and E2 genes are highly conserved and are involved in DNA replication 
and genome encapsidation.  E2 has the added role of regulating the expression of 
the E6 and E7 genes.  Gene E4 facilitates viral assembly and E5 is involved in 
protein upregulation of growth factor receptors (15).  E6 and E7 genes encode for 
proteins that disrupt the cell cycle checkpoints ensuring the cells never leave the 
cell cycle.  This is done by binding to and degrading proteins that would normally 
cause either apoptosis or would regulate terminal differentiation.  For E6, this 
protein is p53 and for E7 it is the Retinoblastoma family of proteins (13).  When a 
HPV genome is integrated into the host‟s genome there is usually disruption of the 
E2 gene.  This leads to a loss in the regulation of E6 and E7 leading to genome 
instability and cancer promotion (15).  
3.5 HPV life cycle 
HPV is an epitheliotropic virus.  Its replication is closely related to the replication 
and differentiation of the epithelial cells that it infects (13).  Under normal conditions, 
basal epithelial cells divide and the daughter cell that is produced will migrate to 
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the suprabasal layers.  They differentiate and thus lose the ability to divide.  This 
process is interrupted by HPV infection (15). 
Initially, infectious viral particles gain access to the basal layers of the epithelium.  
A plausible mode of access is through micro-wounds of the epithelium (13).  In these 
basal cells the viral particles enter the nucleus and viral replication occurs.  The 
virus is maintained in the basal layers at low levels with each infected cell 
containing approximately 50-100 genomes.  With cell division, the virus too divides 
and each daughter cell contains an even number of genomes (15). 
This division is followed by migration of one of the daughter cells into the 
suprabasal layers.  In these upper layers the E6 and E7 genes come into effect.  
They ensure the infected cell does not leave the cell cycle and that HPV replication 
can continue with the use of the host epithelial cells‟ replication machinery.  In the 
upper layers, there is gene amplification.  E1 and E2 are responsible for this 
replication as well as for DNA packaging into capsids.  Finally there is release of 
the newly-formed virions from the cells (15). 
3.6 HPV in oesophageal squamous cell carcinoma 
The role of HPV in oesophageal squamous cell carcinoma was first proposed by 
Syrjänen in 1982 (16).  Since then the pages of medical journals are testament to 
over 60 articles on the subject of the role that HPV has to play in the aetiology of 
oesophageal squamous cell cancer.  
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 The data in the current literature shows vastly divergent results.  A review of the 
literature undertaken by Poljak et al. up until 1997 showed HPV prevalence rates of 
between 0 and 66% of cases of OSCC.  Poljak et al. found in their series no 
evidence of HPV in 120 cases of OSCC (10).  Several factors have been considered 
in the literature in an attempt to elucidate the impact they may have on HPV 
prevalence in OSCC. 
It has been postulated that the differences in the prevalence of HPV in OSCC are 
related to the geographical region in which the study was conducted with HPV 
having a more significant role in areas which are high risk for OSCC (5).  Herbster 
et al. conducted their study in Brazil comparing the HPV prevalence rates among 
two different population groups within Brazil, the one group was from southern 
Brazil, a high incidence area and the second was from south eastern Brazil, a 
medium incidence area.  They demonstrated HPV in 23% of cases from the high 
risk areas as compared to only 8% of the cases from the medium risk area. This 
supports the theory of the causal relationship of HPV in OSCC in geographical 
regions which are high risk for OSCC (17).  Two studies from Iran, a high risk area, 
that have been recently published show conflicting results on this theory. The study 
published by Yahyapour et al. found HPV in 27,7% of their cases (11) which further 
supports this theory, however in a study by Abdirad et al. HPV was only detected in 
8,6% of their cases (18) which is not a significant correlation.   
Biron et al. (19) found an increase incidence of cervical cancer in female patients 
with oropharyngeal squamous cell carcinoma as compared to a control group and 
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postulated frequent HPV co-infection of the two sites in these patients.  
Unfortunately, none of the studies looking at OSCC and HPV commented on the 
incidence of cervical cancer, cervical dysplasia or the prevalence of genital warts in 
the population.  This would have given an estimation as to the overall prevalence 
of HPV in the study population, thus helping with the interpretation of results.  In 
countries with a low or decreasing incidence of HPV related cervical disease, one 
would not expect a significant HPV burden and a negative HPV result would not be 
significant.  The converse would be true in that a positive HPV result in these 
countries would have been a significant result.   
Polymerase chain reaction (PCR) is commonly used and is considered to be the 
most sensitive method of HPV detection (5).  Technical factors with the PCR 
procedure have been cited as a possible reason for the discordant results in the 
literature, especially with respect to the selection of primer sets (10).  The use of the 
L1 region which is highly conserved across many HPV genotypes is most 
frequently used to detect HPV by PCR (10-11, 17-18, 20).  The E6 region has also been 
employed by some (10, 20).  Matsha et al. found that of their 52 HPV positive cases, 
all were positive using the L1 region, however, only 32 were positive with E6 and 
they postulated poor primer design for the discordant results when comparing L1 
and E6 primers (20).  Herbster et al. performed PCR for the L1 gene on all their 
samples in two rounds, the first round used the MY09/MY11 primer set and the 
second round used the GP5+/GP6+ primer pair.  Subsequently, in situ 
hybridisation (ISH) was performed on the samples which were PCR positive.  Of 
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these PCR positive cases, 89% were also positive with ISH.  An equal number of 
PCR negative samples were also tested with ISH and none of them were positive 
(17). 
Several studies have subtyped the HPV that has been detected in their cases of 
OSCC. In Iran high risk HPV 16 and low risk HPV 6 were detected at an equal 
frequency in the HPV positive cases tested by Abdirad et al. (18). The study by 
Yahyapour et al. which was also conducted in Iran also found an equal 
combination of low risk and high types, namely low risk HPV11 and high risk 
HPV45 (11).  Vaiphei et al. found more than one viral type in most of their cases with 
high risk HPV 52 being the most frequent (21).  There does not appear to be a 
correlation between HPV subtype and the development of OSCC suggesting that 
there may be another factor which may play a role in the development of OSCC.  
Of particular interest is the high prevalence of low risk HPV subtypes in the OSCC 
cases. 
The role of HPV in oesophageal cancer can be proven by establishing its role in 
the malignant transformation of oesophageal mucosa.  One could extrapolate that 
HPV infection is responsible for oesophageal cancer if one could provide evidence 
of a step-wise progression from oesophageal mucosa with HPV infection, to 
dysplasia, to carcinoma in situ and then invasive carcinoma of the oesophagus.   
Vaiphei et al. assessed the presence of HPV in OSCC as well as in the adjacent 
mucosa of the same patient.  They detected HPV in 16 of their 23 tumour samples 
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(70%) and in 15 of the 23 adjacent mucosa samples (65%).  Of interest is that high 
risk HPV types were detected in two of the tumour cases but not in their adjacent 
mucosa and the converse was also found with two cases showing high risk HPV in 
the mucosa but not the tumour (21). 
In South Africa, the last few decades have seen a change in the face of medicine, 
a change in disease progression and disease profiles.  HIV is the underlying cause 
that this change stems from.  With the HIV pandemic in many countries, the 
progression to invasive carcinoma of the cervix has been noted to happen at an 
increased frequency in a younger age group among HIV positive individuals as 
compared to their HIV negative age-matched controls (9).  Unfortunately, there are 
no studies that have looked at the HIV status of the patients with OSCC to see if 
there was a trend that mirrors that of cervical cancer and HPV.   
Alcohol and smoking are well recognised risk factors for the development of OSCC 
(4). A retrospective study was performed by Qi et al. and the cases of OSCC were 
compared to matched controls. Smoking and alcohol consumption were assessed 
as independent risk factors.  They found HPV in 38,7% of tumour cases and 29,0% 
of control cases.  In the patients who were non-smoking and non-alcohol 
consuming there was no significant difference in HPV prevalence rates amongst 
cases of OSCC.  In patients who were seropositive for HPV and who were both 
smokers and alcohol consuming, there was a significantly higher risk for the 
development of OSCC (22).  The increased prevalence of HPV in OSCC amongst 
smokers was mirrored by Vaiphei et al. (21). This association however was not 
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confirmed by Herbster et al. who found no significant differences in HPV 
prevalence amongst smokers as compared to non-smokers or amongst people 
who consumed alcohol and those who did not. They did not assess if there was a 
difference in HPV prevalence in patients who both smoked and drank alcohol (17). 
South Africa is a known high risk area for OSCC and since the 1960‟s the 
incidence rate has been increasing to almost epidemic proportions (7).  A study 
conducted in the Transkei region of South Africa detected HPV DNA by PCR in 52 
of 114 (46%) of their OSCC cases as well as in 7,3% of their normal control cases.  
The predominant subtype was HPV 11 found in 43% of cases followed by HPV 39, 
HPV 16 and HPV52.  Their data supports the aetiological association of HPV and 
OSCC (20).
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CHAPTER 4 
4.0 MATERIALS AND METHODS 
4.1 Clinical setting 
This study was carried out in the Anatomical Pathology Department of Chris Hani 
Baragwanath Hospital which is located in Soweto, Gauteng, South Africa. This is a 
large hospital with approximately 3200 beds which provides health care primarily to 
residents of greater Soweto.  However, it is also a tertiary care academic hospital 
and functions as a major referral centre from other areas of South Africa. 
4.2 Sample 
The National Health Laboratory Services database at Chris Hani Baragwanath 
Hospital, DISA, was searched for all archived cases of OSCC that were diagnosed 
between 01 January 2009 and 31 December 2010. The search was undertaken 
using the SNOMED codes for “esophagus” and “squamous cell carcinoma, NOS”. 
The pathological reports, slides and paraffin wax embedded blocks were retrieved.  
All of the cases were allocated a consecutive number and the names of the 
patients were not revealed to anyone except the principal investigator. 
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4.3 Inclusion and exclusion criteria 
 Patients younger than 18 years of age were excluded. 
 Duplications were excluded (biopsy, surgical specimens or recurrences for the 
same patient). 
 Cases in which the material in the paraffin wax block was cut through or 
inadequate (insufficient tissue within the tissue block to cut the 4 x 10μm 
sections for the PCR) were excluded. 
 Only cases of primary squamous cell carcinoma were included. 
4.4 Histological assessment 
The archived slides for each case were examined by the student in order to 
confirm the diagnosis and to ensure that enough representative material was 
available in the block.  Enough material was defined as the presence of invasive 
carcinoma which was more than focal single cell invasion. In addition, if multiple 
ribbons or levels had previously been examined, each ribbon or level was 
examined to ensure that the invasive component had not been cut away and was 
still present on the last ribbon or level in such cases. Each case was histologically 
assessed for the presence of squamous cell carcinoma.  In addition, the surface 
epithelium of each case was assessed for the presence of condylomatous atypia 
which is a morphologic indication of HPV infection, the features of which include 
parakeratosis, papillomatosis, nuclear atypia, multinucleation, perinuclear 
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vacuolation and basal cell hyperplasia. 
4.5 Gathering and analysis of data 
The patients‟ age, gender and race were taken from the biopsy request forms and 
hospital sticker.  This data together with the number identifying the case were 
captured on the data collection form (Appendix 1) and when complete, they were 
transferred onto an Excel Spreadsheet for analysis. 
4.6 Polymerase chain reaction 
 Sample collection 
The archived paraffin-embedded formalin-fixed tissue blocks of these cases were 
retrieved.  From each block, 4 x 10μm sections were cut into Eppendorf tubes.  
Between each case the work surface was sterilised, the technologist changed 
gloves and the microtome blade was changed to avoid cross contamination 
between cases.   For each step and with each sample, a new pipette tip and tube 
was used to avoid cross contamination. Each new tube was clearly labelled with 
the study number prior to being used. 
PCR was performed as per departmental protocol as described below. 
 Removal of paraffin from the paraffin-embedded tissue blocks 
Prior to starting, the work surface was decontaminated by wiping down the surface 
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using a 3% Virkon solution followed by exposure with UV light for ten minutes.  To 
remove the paraffin, 1000μL of Xylene was added to each labelled Eppendorf tube.  
Each sample underwent vortex vigorously for 15 seconds to mix the paraffin and 
Xylene.  The samples were then placed in a centrifuge at 13000rpm for five 
minutes.  The supernatant was then removed by pipetting.  The above steps were 
then repeated.  To remove any residual Xylene, each sample was centrifuged at 
13000rpm for a further five seconds.  The supernatant was then removed with a 
pipette.  To remove any residual Xylene, 1200μL of ethanol (96-100%) was added 
to each Eppendorf tube.  Each sample underwent gentle vortex for 15 seconds to 
mix the alcohol with the tissue.  The samples were then placed in a centrifuge at 
13000rpm for five minutes.  The supernatant was then removed by pipetting.  The 
above steps were then repeated.  To remove any residual alcohol, each sample 
was centrifuged at 13000rpm for a further five seconds.  The supernatant was then 
removed with a pipette.  Each tube was then opened and placed in a Dry Bath at 
37˚C for 15 minutes allowing any remaining ethanol to evaporate. 
 DNA extraction 
A proteinase buffer solution was then made by combining 1800μL of Elution buffer 
and 200μL of proteinase K (10%) and mixing by vortexing for a few seconds.  Into 
each Eppendorf tube, 200μL of the proteinase buffer was added to the tissue 
sections and mixed by vortexing for a few seconds.  The tubes were then placed in 
an incubator overnight.  The incubator lysed the tissue and released the DNA by 
agitating the tissue at 56˚C.  The following day the tubes were removed from the 
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incubator and 200μL of Buffer AL was added to each tube.  Each sample was then 
vortexed for 15 seconds and incubated at 70˚C for 10 minutes to inactivate the 
proteinase K.  The samples were then removed from the incubator and briefly 
centrifuged to remove any drops from the inside of the lid.  The supernatant was 
then removed and added to a new labelled tube.  To the supernatant, 200μL of 
ethanol (96-100%) was added and mixed by vortexing for 15 seconds.  For the 
next few steps of the DNA isolation process, a QIAGEN DNA Micro Kit (Qiagen, 
Germany) was used.  The supernatant mixture was carefully added to the Qiagen 
tube ensuring the QIAamp Spin Column was not touched or damaged.  The tubes 
were then closed and centrifuged at 8000rpm for one minute.  The QIAamp Spin 
column was then removed from the tube with the filtrate and placed in a new 
labelled 2ml collection tube.  The tube with the filtrate was discarded.  To each 
tube, 500μL of Buffer AW1 was added and then the tubes were centrifuged at 
8000rpm for 1 minute.  The QIAamp Spin column was then removed from the tube 
and placed in a new labelled 2ml collection tube.  The old collection tube was 
discarded.  To each tube, 500μL of Buffer AW2 was added.  The tubes were 
centrifuged at 8000rpm for one minute and then at 13000rpm for three minutes to 
dry the membrane.  The QIAamp Spin column was then removed from each tube 
and placed in a new labelled 2ml collection tube.  The old collection tube was 
discarded.  Into each new tube, 30μL of Buffer AE was added to the centre of the 
membrane and allowed to stand for one minute at room temperature.  The tubes 
were then centrifuged at 8000rpm for one minute.  The centrifuge removed the 
DNA from the QIAamp Spin Column membrane into the collecting tube.  New 
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collection tubes were taken and labelled.  From the old collection tubes, the 
QIAamp Spin Columns were removed and discarded and the fluid transferred to 
the new collection tubes with pipettes.  These tubes containing the DNA solution 
were then refrigerated at 2-10C until used. 
 DNA quantification check 
To assess the quantity of the DNA obtained, a Thermo Scientific NanoDrop 1000 
spectrophotometer was used.  First the spectrophotometer was calibrated with 2µl 
of Buffer AE.  For each sample, 2µl was added to the spectrophotometer and a 
reading obtained.  The results of the DNA extraction and quantification are 
provided in Appendix 2. 
 DNA quality check using the beta-globin gene 
A number of components may cause inhibition of PCR by interfering with one of 
the enzymatic reactions of PCR.  An internal control in the form of β-globin is used 
to monitor the DNA extraction procedure and check for possible inhibition.  β-globin 
is used as it is a house-keeping gene that is found in all nucleated host cells.  
Template DNA of the β-globin gene is co-purified when DNA extraction is 
performed thus monitoring the DNA extraction procedure.  Detection of β-globin by 
real-time PCR confirms that inhibitors are not present. 
In this study, the β-globin gene was amplified using the primer pair PCO4 (forward) 
and GH20 (reverse) (Table 1).  The β-globin master mix was made in a final 
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reaction volume of 18 µl and contained 10.0 µl of 2X SensiMixTM (Bioline, United 
Kingdom), 2.0 µl of Primer Mix (PCO4 [10mM] and GH20 [10mM]) (Whitehead 
Scientific, United Kingdom) and 6.0 µl of sterile PCR grade ddH2O (Adcock Ingram, 
South Africa). (Appendix 3).  The PCR master mix was made by adding the various 
components in order and mixed by gentle pipetting 
Table 1: Sequence of the oligonucleotides used as β -globin PCR primers 
Gene Primers Sequences Size (bp) 
β-globin PCO4 (forward) 
GH20 (reverse) 
5‟-CAACTTCATCCACGTTCACC-3‟ 
5‟-GAAGAGCCAAGGACAGGTAC-3‟ 
268 
 
The specimen was prepared for PCR in a labelled 0,2ml tube by adding 18µl from 
the β-globin PCR master mix and 2.0µl of the DNA isolate.  The tubes were placed 
in the sample tray which was in turn placed in the Rotor-Gene 6000 real-time 
system.  The thermal profile is indicated in Appendix 4.  The average melting point 
of the β-globin amplicon should be 85,5°C +/- 1°C.  This amplicon can be revealed 
as a 268bp on an agarose gel. 
 PCR procedure 
The HPV L1 gene was amplified using the primer pair GP5+ (forward) and GP6+ 
(reverse) (Table 2).  The PCR master mix was made for all reactions in a final 
reaction volume of 50 μL  and contained, 5.0 µl of 10X Reaction Buffer (with MgCl2, 
15mM) (Roche, Germany), 4.0 µl of MgCl2 (25 mM) (Roche, Germany), 1.0 µl of 
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dNTPs (10 mM each) (Roche, Germany), 1.0 µl of GP5+ (10 µM) (Whitehead 
Scientific, United Kingdom), 1.0 µl of GP6+ (10 µM) (Whitehead Scientific, United 
Kingdom) and 0.4 µl of Taq DNA polymerase (5 U/µl) (Roche, Germany). 
(Appendix 5).  The master mix reaction contained 5 µl of template DNA.  PCR 
master mix was made by adding the various components in order and mixed by 
gentle pipetting.  This amplicon can be revealed as a 150bp on an agarose gel. 
Table 2: Sequence of the oligonucleotides used as HPV PCR primers 
Gene Primers Sequences Size (bp) 
HPV L1 GP5+ (forward) 
GP6+ (reverse) 
5‟-TTTGTTACTGTGGTAGATACTAC-3‟ 
5‟-GAAAATAAACTGTAAATCATATTC-3‟ 
150 
 
The DNA concentration of the amplified product varied between the samples with 
an average DNA concentration of 166.1 Ng/μL.  The tubes were placed in the 
sample tray which was in turn placed in the GeneAmp 9700 (Applied Biosystems) 
PCR System for PCR cycling.  The thermal profile is indicated in Appendix 6 and 
was as follows: initial denaturation at 94°C for 4 minutes, 40 cycles with the cycling 
profile of step 1 at 95°C for 1 minute, step 2 at 55°C for 1 minute and step 3 at 
72°C for 1 minute and the final extension at 72°C for 5 minutes.  
Each step of the procedure was controlled with positive and negative controls. 
Positive controls were obtained from previously proven HPV positive cases. For 
negative controls, a „no template‟ control was used in which nuclease-free water 
was substituted as a template. Every HPV PCR run contained at least two positive 
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controls and one negative control. 
 Electrophoresis 
A 3% ethidium bromide stained agarose gel was used to visualise the PCR 
product. The 3% agarose gel was prepared using 3g of Agarose (Bioline, United 
Kingdom) and 100ml of TAE buffer (Invitrogen, United Kingdom) which contains 
ethidium bromide.  On a parafilm 1μl of loading dye was mixed with 20μl of each 
amplified PCR product and loaded into the wells.  The first well contained the DNA 
ladder (GeneRuler 50bp DNA Ladder) (Fermentas, Canada) which was prepared 
by mixing 2μl of the DNA ladder with 2μl of loading dye and 12μl of Sabax water.  
The subsequent wells contained the controls and then the samples.  The samples 
were separated for 45 minutes at 100V and then photographed. 
4.7 Control and reliability of the data 
Ten cases of normal oesophagus were identified and tested for the presence of 
HPV DNA in exactly the same way using PCR.  These cases were included to 
assess for the presence of HPV in the oesophagus in a population without OSCC. 
The diagnosis of squamous cell carcinoma is straight forward and the scientists in 
the molecular biology laboratory are very experienced at reading electrophoresis 
gels.  Thus it was not considered necessary to perform intraexaminer or 
interexaminer reliability tests. Results of the data were regarded as both reliable 
and reproducible. 
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4.8 Data analysis 
Data analysis was performed using appropriate techniques and software.  
Microsoft Excel 2010 ® was used to store data as a spread sheet and statistical 
calculations were performed in STATISTICA version 11 by StatSoft, Inc. (2012) 
[www.statsoft.com].  
Descriptive statistics in the form of mean, median and standard deviation were 
used to describe the ages; and frequency analysis was used to describe the 
gender and race of the patients.  The PCR results reflected whether there was a 
presence or absence of HPV DNA. 
4.9 Statistical significance 
In order to compare the categorical data HPV positivity and negativity was 
statistically compared in the OSCC and the normal control cases.  As the data was 
to be categorical the Chi-square test (Yates correction) was used unless one of the 
categories was less than 10 in which case a Fisher‟s exact was used.  A p value of 
<0.05 indicated statistical significance. 
4.10 Ethical consideration 
The Department of Anatomical Pathology has been granted blanket clearance by 
the Committee for Research on Human Subjects (medical) of the University of the 
Witwatersrand for the use of archived slides and tissue blocks for investigative 
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procedures and medical biology procedures.   Nevertheless, an ethics application 
has also been submitted and clearance for this investigation has been received 
under clearance number M110404. (Appendix 7). 
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CHAPTER 5 
5.0 RESULTS 
5.1 Sample size 
A total of 96 cases were identified from the NHLS database search and met the 
inclusion criteria for the study.  In one of these cases, DNA was not amplified with 
the β-globin gene and was subsequently excluded from the study.  Ten biopsies 
showing normal oesophageal mucosa were included as controls. 
5.2 Demographics 
The study population comprised OSCC from 58 males and 38 females with a male 
to female ratio of 1,53:1.  
The age of the study population ranged from 26 to 94 years with a mean of 62.3 
years (SD=12,37) and a median of 61 years (Figure 1).   The mean ages of males 
was 60,6 years and in females the mean age was 64,8 years (Figure 2). This 
difference was not statistically significance (p=0.1).  Age was not available for two 
patients, one male and one female.  
Race was only recorded in 37 of the cases (38,5%).  In all these cases the race 
was recorded as “Black”. 
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Figure 1: Histogram of the ages measured in years in the study population of 
patients with OSCC with the expected normal distribution of cases with this 
age range (n=94) 
 
Figure 2: Boxplot of age in years by gender as found in the study population 
of patients with OSCC 
 27 
5.3 Histological features 
Histological assessment confirmed oesophageal squamous cell carcinoma in all 
the cases (Figure 3). 
 
Figure 3: Invasive squamous cell carcinoma of the oesophagus (H&E, x20) 
Histological assessment of the oesophageal squmaous cell carcinoma cases 
showed evidence of condylomatous atypia in two of the 96 (2,1%) cases (Table 3, 
Figure 4 and Figure 5).  Both of these were biopsy specimens.   
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Table 3: Presence of condylomatous atypia in cases of oesophageal 
squamous cell carcinoma and normal control specimens 
 Condylomatous atypia 
 Present Absent 
OSCC 2/96 94/96 
Normal biopsy 0/10 10/10 
 
 
Figure 4: Invasive squamous cell carcinoma of the oesophagus (H&E, x100) 
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Figure 5: High power view of Figure 4 showing condylomatous atypia of the 
mucosa (H&E, x200) 
There was no condylomatous atypia or invasive squamous cell carcinoma in the 
normal control cases. 
5.4 PCR results 
PCR was performed on 95 cases of oesophageal squamous cell carcinoma using 
the GP5+ and GP6+ primers.  All 95 cases failed to demonstrate the presence of 
HPV DNA (Figure 6 and Table 4).  The β-globin gene would not amplify in one 
case of OSCC and it was deemed unsuitable for the HPV PCR reaction. 
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All ten cases of the normal mucosa tested negative for the presence of HPV DNA.  
In every PCR run the two positive HPV controls were positive producing the 
expected DNA fragment of150bp on electrophoresis.  The negative control was 
negative in every PCR run. 
As all of the cases in both groups were negative, the Chi-square test could not be 
performed. 
1             2             3             4             5 
 
 
 
 
 
Figure 6: A 3% ethidium bromide stained agarose gel run at 100V for 45 
minutes showing DNA fragments produced by PCR amplification of the L1 
gene from HPV using GP5+/GP6+ primers  
Lane 1: 50bp DNA ladder; Lane 2: OSCC case; Lanes 3-4: Positive controls; Lane 
5: Negative control 
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Table 4: Detection of HPV DNA in cases of oesophageal squamous cell 
carcinoma and normal control specimens 
 HPV PCR 
 Negative Positive 
OSCC 95/95 0/95 
Normal biopsy 10/10 0/10 
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CHAPTER 6 
6.0 DISCUSSION 
6.1 Major findings of the study 
In this study HPV could not be demonstrated in any cases of OSCC that were 
diagnosed at Chris Hani Baragwanath Hospital in 2009 and 2010.  This proves that 
there is no role for HPV in the aetiology of OSCC in this study population.  This is a 
significant finding given the HPV burden in South Africa. 
The incidence rate of OSCC in this study population was higher in men as 
compared to women which correlates with that reported globally. (4)    
The mean age of the study population was 62,3 years. This is comparable to the 
mean age  that was reported in other studies such as 59,6 years by Poljak et al. (10) 
and 58.84 years by  Abdirad et al. (18).   
Although the race of the patients was only recorded in 38,5% of the cases, all the 
patients were of the same racial demographic.  This study was conducted at Chris 
Hani Baragwanath Hospital in Soweto which although providing care to patients of 
all races, is predominantly frequented by black patients.  This may explain the 
finding of only a single racial profile in this study. 
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6.2 The meaning of the study and why it is important 
HPV has been proven to be oncogenic and successful screening programmes 
have been instituted and a HPV vaccine has been developed to further assist in 
reducing the burden of HPV-related disease. Should HPV have been detected this 
may have impacted on management protocols with respect to future screening for 
OSCC and HPV as well as guidelines for implementing the HPV vaccine.  
However, given the complete absence of HPV in these cases it is evident that 
other aetiological agents are at work in this study population that are unrelated to 
HPV.  At the present time there is no need for HPV screening programmes or 
vaccine schedules in respect to OSCC. 
6.3 Similar studies 
The results shown in this study are comparable to those found previously by other 
authors such as Poljak et al. in Poland (10).  Although Abdirad et al. found HPV in 
isolated cases they found the prevalence of HPV in OSCC too low to be significant 
(18).  Both of these studies made use of the L1 region for HPV detection which was 
the same primer used in this study. In conflict to this, Herbster et al. (17) and 
Yahyapour et al. (11) found statistically significant HPV levels in their cases of 
OSCC also using the L1 region primers for PCR.  The reason for the discordance 
of results cannot be explained by the risk for OSCC prevalence in a country as 
previously suggested (5) or by method of detection (10) although technical issues 
 34 
such as cross contamination should be considered. 
In a previous study from South Africa by Matsha et al., a significant HPV 
prevalence was found in cases of OSCC and HPV was also detected in normal 
oesophageal biopsies. The study was conducted in a different region, namely the 
Transkei region in South Africa which is a high risk area for OSCC.  It is also 
considered a rural area as compared to the urbanised area of Soweto where this 
study was conducted.  They predominantly found HPV 11 which is a low risk 
oncogenic subtype of HPV (20).  This raises the possibility that this may have been 
a co-incidental finding as opposed to a significant association. Traditional risk 
factors such as smoking and alcohol consumption in this population was not 
specifically addressed in this study.  In particular the consumption of home-brewed 
beer was not considered and this may have influenced the HPV results. 
6.4 Alternative explanations of the findings 
The findings which have been previously published show HPV prevalence ranging 
from 0-66% (10).  It is possible that there is no correlation between OSCC and HPV 
with only incidental HPV DNA being detected.  The role of cross contamination has 
not been specifically addressed and standard protocols to avoid cross 
contamination during PCR were used in all studies, however, cross-contamination 
at the time of biopsy has not been considered.  Many studies used the same 
GP5+/GP6+ primer pair to the L1 gene as was used in this study which eliminates 
significant variables with respect to the study design. 
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The two cases demonstrating condylomatous atypia subsequently proved to be 
negative for HPV by PCR.  This may be as a result of an artefact that was 
introduced during the processing of the tissue or as a result of koilocytic mimics 
such as glycogenation of the cytoplasm. 
6.5 Clinical relevance 
These findings are clinically relevant in that immediate management protocols 
need not be altered at this point in time.  HPV has not been shown to be an 
important factor in this study population and is not a factor that needs to be 
addressed by clinicians. 
6.6 Study limitations 
Only a single HPV DNA primer set was used in this study namely primers to the L1 
region.  Once the first round were proven negative, a different primer set or method 
of HPV detection could have been used on all the cases or a random subset to 
confirm the negative results. 
This study was based on all cases occurring within a specified time frame that 
fulfilled eligibility criteria and not a specific sample size.  A post-hoc power analysis 
was not possible as the incidence rates between the comparative groups was the 
same.  An attempt was made to calculate sample size a priori.  It was also not 
possible to calculate sample size as the expected incidence of HPV in the 
oesophagus is zero and if the incidence is based on previous literature the range of 
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0-66% quoted in the literature (10) is too wide to estimate sample size. Poljak et al. 
performed a literature review of all 35 studies occurring prior to 1997, with only two 
of these studies having more cases than the 95 OSCC cases tested here (10). Of 
the most recent studies published on this subject, Yahyapour et al. had 177 cases 
of which 27,7% detected HPV (11), Qi et al. had 225 cases of which 38,7% detected 
HPV (22) and Vaiphei et al. had only 23 OSCC samples in which HPV detected in 
87% of their cases (21).  The sample size differed between these studies although 
HPV positivity was detected in all of them. A sample size of 95 cases in this study 
is not out of keeping with that published in the literature although a longer time 
frame could have been considered in order to increase the sample size. 
6.7 Further suggestions for research 
Correlation with HPV screening programmes could be considered in future studies.  
Once the predominant HPV type in the given population was identified from Pap 
smear screening programmes, additional more specific primer sets could be 
considered. 
It would also be worthwhile correlating Pap smear results in patients with proven 
OSCC to determine if there is any correlation between HPV prevalence on Pap 
smear and HPV prevalence in OSCC cases. Balamurugan et al. (23) found a 
statistically significant increase in OSCC among survivors of cervical squamous 
cell carcinoma although they attributed this finding to tobacco-use and not HPV 
infection. 
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CHAPTER 7 
7.0 CONCLUSION 
HPV is a common infection in the South African population and is known to be 
carcinogenic in other sites.  Its role in OSCC has remained controversial, however, 
this study does not support the theory that HPV has a role to play in OSCC. 
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Appendix 1: Data Collection Sheet 
 
Research number:   
Case number:   
Clinical details: Age:  
 Gender:  
 Race:  
Histology: Diagnosis:  
 Condylomatous atypia:  
HPV PCR 
(Positive or negative): 
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Appendix 2: DNA Extraction and Quantification Log 
 44 
 45 
 46 
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Appendix 3: β-globin Master Mix for PCR 
PCR Reaction 1X X36 
2X SensiMixTM 10.0 μl 360 μl 
Primer Mix (10mM) 2.0 μl 72 μl 
Sterile PCR grade ddH2O 6.0 μl 216 μl 
Total 18.0 μl  
Sample 2.0 μl  
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Appendix 4: β-globin PCR Profile 
Cycle Cycle point 
Hold @ 95°C, 10 minutes  
Cycling (50 repeats) Step 1 @ 95°C, hold 10 seconds 
 Step 2 @ 60°C, hold 10 seconds 
 Step 3 @ 72°C, hold 15 seconds 
Final extension @ 85,5°C for 5 minutes  
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Appendix 5: HPV Master Mix for PCR 
PCR Reaction 1X X28 
Sterile PCR grade ddH2O 32.6 μl 912.8 μl 
10X Reaction Buffer (with 
MgCl2, 15mM), 
5.0 μl 140 μl 
MgCl2 (25 mM) 4.0 μl 112 μl 
dNTPs (10mM each) 1.0 μl 28 μl 
GP5+ (10 μM) 1.0 μl 28 μl 
GP6+ (10 μM) 1.0 μl 28 μl 
Taq DNA polymerase (5 
U/µl). 
0.4 μl 11.2 μl 
Total 45.0 μl  
Sample 5.0 μl  
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Appendix 6: HPV PCR Profile 
Cycle Cycle point 
Hold @ 94°C, 4 minutes  
Cycling (40 repeats) Step 1 @ 95°C, hold 1 minute 
 Step 2 @ 55°C, hold 1 minute 
 Step 3 @ 72°C, hold 1 minute 
Final extension @ 72°C for 5 minutes  
Hold @ 4°C ∞  
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